博瑞医药：首次回购5.588万股

Core Viewpoint - The company, Borui Pharmaceutical, has initiated its first share buyback on October 30, 2025, through the Shanghai Stock Exchange, indicating a strategic move to enhance shareholder value [1] Summary by Categories Share Buyback Details - The company repurchased 55,880 shares, which represents 0.0132% of its total share capital [1] - The highest price for the repurchased shares was 54.28 yuan per share, while the lowest price was 52.96 yuan per share [1] - The total amount spent on the buyback was approximately 2.993933 million yuan, excluding stamp duty and transaction commissions [1] Compliance and Future Actions - The share buyback is in accordance with relevant laws and regulations, as well as the company's buyback plan [1] - The company will make buyback decisions based on market conditions within the designated buyback period and will fulfill its information disclosure obligations in a timely manner [1]